04:31 PM EDT, 08/29/2025 (MT Newswires) -- Sarah Boyce, Director, President and CEO, on August 28, 2025, sold 25,000 shares in Avidity Biosciences ( RNA ) for $1,234,700. Following the Form 4 filing with the SEC, Boyce has control over a total of 305,871 common shares of the company, with 305,871 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990125000168/xslF345X05/wk-form4_1756499311.xml